195 related articles for article (PubMed ID: 7660885)
21. Mammalian glycinamide ribonucleotide transformylase. Kinetic mechanism and associated de novo purine biosynthetic activities.
Caperelli CA
J Biol Chem; 1989 Mar; 264(9):5053-7. PubMed ID: 2925682
[TBL] [Abstract][Full Text] [Related]
22. A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors.
Habeck LL; Leitner TA; Shackelford KA; Gossett LS; Schultz RM; Andis SL; Shih C; Grindey GB; Mendelsohn LG
Cancer Res; 1994 Feb; 54(4):1021-6. PubMed ID: 8313357
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antifolate activity of 5-methyl-5,10-dideaza analogues of aminopterin and folic acid and an alternative synthesis of 5,10-dideazatetrahydrofolic acid, a potent inhibitor of glycinamide ribonucleotide formyltransferase.
Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Thorndike J; Sirotnak FM
J Med Chem; 1988 Nov; 31(11):2164-9. PubMed ID: 3184124
[TBL] [Abstract][Full Text] [Related]
24. Effect of nitrous oxide-induced inactivation of vitamin B12 on glycinamide ribonucleotide transformylase and 5-amino-4-imidazole carboxamide transformylase.
Deacon R; Perry J; Lumb M; Chanarin I
Biochem Biophys Res Commun; 1983 Apr; 112(1):327-31. PubMed ID: 6838615
[TBL] [Abstract][Full Text] [Related]
25. Pemetrexed safety and dosing strategy.
Niyikiza C; Hanauske AR; Rusthoven JJ; Calvert AH; Allen R; Paoletti P; Bunn PA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):24-9. PubMed ID: 12571807
[TBL] [Abstract][Full Text] [Related]
26. Structures of apo and complexed Escherichia coli glycinamide ribonucleotide transformylase.
Almassy RJ; Janson CA; Kan CC; Hostomska Z
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6114-8. PubMed ID: 1631098
[TBL] [Abstract][Full Text] [Related]
27. MTA, A Novel Multitargeted Antifolate: from preclinical to phase I and beyond. Proceedings of a meeting. Ixtapa, Mexico, March 13-15, 1998.
Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-110. PubMed ID: 10610578
[No Abstract] [Full Text] [Related]
28. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents.
Calvert H
Semin Oncol; 1999 Apr; 26(2 Suppl 6):3-10. PubMed ID: 10598549
[No Abstract] [Full Text] [Related]
29. Synthesis of 5,11-methenyltetrahydrohomofolate and its antifolate activity in vitro.
Caperelli CA; Domanico P; Benkovic SJ
J Med Chem; 1981 Sep; 24(9):1086-8. PubMed ID: 7288824
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of chicken liver 5-aminoimidazole-4-carboxamide ribonucleotide transformylase by 5,8-dideaza analogues of folic acid.
Mueller WT; Smith GK; Benkovic SJ; Hynes JB
Biochem Pharmacol; 1988 Feb; 37(3):449-51. PubMed ID: 3337744
[TBL] [Abstract][Full Text] [Related]
31. Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514).
Jones RJ; Twelves CJ
Expert Rev Anticancer Ther; 2002 Feb; 2(1):13-22. PubMed ID: 12113062
[TBL] [Abstract][Full Text] [Related]
32. Substrate specificity of glycinamide ribonucleotide transformylase from chicken liver.
Antle VD; Liu D; McKellars BR; Caperelli CA; Hua M; Vince R
J Biol Chem; 1996 Mar; 271(11):6045-9. PubMed ID: 8626389
[TBL] [Abstract][Full Text] [Related]
33. Update on antifolate drugs targets.
Costi MP; Ferrari S
Curr Drug Targets; 2001 Jun; 2(2):135-66. PubMed ID: 11469716
[TBL] [Abstract][Full Text] [Related]
34. Contributions of protein structure-based drug design to cancer chemotherapy.
Jackson RC
Semin Oncol; 1997 Apr; 24(2):164-72. PubMed ID: 9129687
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of HKSV28 cell growth by 5,11-methenyl-tetrahydrohomofolate.
Slieker LJ; Benkovic SJ
Mol Pharmacol; 1984 Mar; 25(2):294-302. PubMed ID: 6700575
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of inhibitors of folate-dependent enzymes as antitumor agents.
Taylor EC
Adv Exp Med Biol; 1993; 338():387-408. PubMed ID: 8304144
[No Abstract] [Full Text] [Related]
37. Biochemistry and pharmacology of glycinamide ribonucleotide formyltransferase inhibitors: LY309887 and lometrexol.
Mendelsohn LG; Shih C; Schultz RM; Worzalla JF
Invest New Drugs; 1996; 14(3):287-94. PubMed ID: 8958184
[TBL] [Abstract][Full Text] [Related]
38. L(-)-10-Formyltetrahydrofolate is the cofactor for glycinamide ribonucleotide transformylase from chicken liver.
Smith GK; Benkovic PA; Benkovic SJ
Biochemistry; 1981 Jul; 20(14):4034-6. PubMed ID: 7284307
[TBL] [Abstract][Full Text] [Related]
39. Mammalian glycinamide ribonucleotide transformylase: purification and some properties.
Caperelli CA
Biochemistry; 1985 Mar; 24(6):1316-20. PubMed ID: 3986180
[TBL] [Abstract][Full Text] [Related]
40. Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferase.
Baldwin SW; Tse A; Gossett LS; Taylor EC; Rosowsky A; Shih C; Moran RG
Biochemistry; 1991 Feb; 30(7):1997-2006. PubMed ID: 1993209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
